Dr Reddys Laboratories RDY
NYSE RDY
$12.17 +0.06 (+0.50%)
At close: Aug 20, 2026 · 12:48 PM UTC

Dr Reddys Laboratories (RDY) Deferred Taxes (2009)

Dr Reddys Laboratories (RDY) posted quarterly Deferred Taxes of -$15.0 million for Q4 2009, down 225.0% quarter-over-quarter from $12.0 million in Q3 2009.

Dr Reddys Laboratories (RDY) Deferred Taxes (2009) Analysis & Trends

Dr Reddys Laboratories' Deferred Taxes history runs 1 years deep, the most recent figure standing at -$15.0 million for Q4 2009.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Haleon 43.98 Bn 43.02 Bn - -
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn 25.00 Mn
3 Zoetis 31.79 Bn 30.11 Bn 1.05 Bn -33.00 Mn
4 Takeda Pharmaceutical 28.69 Bn 22.89 Bn 5.10 Bn -
5 United Therapeutics 22.25 Bn 19.58 Bn 683.80 Mn 25.70 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -124.50 Mn
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn -25.30 Mn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Alkermes 8.15 Bn 7.49 Bn 397.90 Mn 9.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2009 -15.00 Mn
Sep 30, 2009 12.00 Mn
Jun 30, 2009 15.00 Mn